ET-28 * COMBINATION THERAPY WITH MET TYROSINE KINASE INHIBITOR EMD1214063 AND BEVACIZUMAB
Publication
, Journal Article
Keir, S; Roskoski, M; Gasinski, D; Friedman, H; Bigner, D
Published in: Neuro-Oncology
November 1, 2014
Duke Scholars
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2014
Volume
16
Issue
suppl 5
Start / End Page
v85 / v85
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Keir, S., Roskoski, M., Gasinski, D., Friedman, H., & Bigner, D. (2014). ET-28 * COMBINATION THERAPY WITH MET TYROSINE KINASE INHIBITOR EMD1214063 AND BEVACIZUMAB. Neuro-Oncology, 16(suppl 5), v85–v85. https://doi.org/10.1093/neuonc/nou255.28
Keir, S., M. Roskoski, D. Gasinski, H. Friedman, and D. Bigner. “ET-28 * COMBINATION THERAPY WITH MET TYROSINE KINASE INHIBITOR EMD1214063 AND BEVACIZUMAB.” Neuro-Oncology 16, no. suppl 5 (November 1, 2014): v85–v85. https://doi.org/10.1093/neuonc/nou255.28.
Keir S, Roskoski M, Gasinski D, Friedman H, Bigner D. ET-28 * COMBINATION THERAPY WITH MET TYROSINE KINASE INHIBITOR EMD1214063 AND BEVACIZUMAB. Neuro-Oncology. 2014 Nov 1;16(suppl 5):v85–v85.
Keir, S., et al. “ET-28 * COMBINATION THERAPY WITH MET TYROSINE KINASE INHIBITOR EMD1214063 AND BEVACIZUMAB.” Neuro-Oncology, vol. 16, no. suppl 5, Oxford University Press (OUP), Nov. 2014, pp. v85–v85. Crossref, doi:10.1093/neuonc/nou255.28.
Keir S, Roskoski M, Gasinski D, Friedman H, Bigner D. ET-28 * COMBINATION THERAPY WITH MET TYROSINE KINASE INHIBITOR EMD1214063 AND BEVACIZUMAB. Neuro-Oncology. Oxford University Press (OUP); 2014 Nov 1;16(suppl 5):v85–v85.
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2014
Volume
16
Issue
suppl 5
Start / End Page
v85 / v85
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences